P
Paul P. Lee
Researcher at University of Michigan
Publications - 385
Citations - 20759
Paul P. Lee is an academic researcher from University of Michigan. The author has contributed to research in topics: Glaucoma & Health care. The author has an hindex of 61, co-authored 381 publications receiving 17901 citations. Previous affiliations of Paul P. Lee include Massachusetts Eye and Ear Infirmary & Durham University.
Papers
More filters
Journal ArticleDOI
Changes in Incidence of Diabetes Mellitus-Related Eye Disease Among US Elderly Persons, 1994-2005
TL;DR: Reductions in rates of diabetic retinopathy among persons newly diagnosed with diabetes enrolled in Medicare from 1994 to 2004 and concurrent improvements in primary care for diabetes suggest that better primary care has had an effect on the Medicare population, despite increasing rates of other adverse outcomes.
Journal ArticleDOI
Rates of glaucoma medication utilization among persons with primary open-angle glaucoma, 1992 to 2002.
TL;DR: Use of beta-blockers and miotics decreased, but utilization rates increased substantially for alpha-agonists, combination beta- blocker-carbonic anhydrase inhibitors, and especially prostaglandin analogs.
Journal ArticleDOI
Glaucoma in the United States and europe: predicting costs and surgical rates based upon stage of disease.
Paul P. Lee,Simon P Kelly,Richard P. Mills,Carlo Enrico Traverso,John G. Walt,John Doyle,Laura M. Katz,Lisa R. Siegartel +7 more
TL;DR: Increases in annual cost were related to higher baseline IOP, higher baseline stage, medication, and surgery, and significant potential savings and reductions in annual healthcare burden are possible if patients are diagnosed and treated at earlier stages of glaucoma.
Journal ArticleDOI
Cataract surgery after trabeculectomy.
Steve K. L. Seah,Aliza Jap,João Antonio Prata,George Baerveldt,Paul P. Lee,Dale K. Heuer,Don S. Minckler +6 more
TL;DR: Intraoperative complications during cataract surgery, particularly vitreous loss, were associated with poor IOP control and eyes with previous successful trabeculectomies had higher IOPs and required more medications after subsequent cataracts surgeries.
Journal ArticleDOI
Trabeculectomy in pseudophakic patients: postoperative 5-fluorouracil versus intraoperative mitomycin C antiproliferative therapy.
João Antonio Prata,Donald S. Minckler,George Baerveldt,Paul P. Lee,Laurie LaBree,Dale K. Heuer +5 more
TL;DR: The results suggest that 5-FU and MMC antiproliferative therapy are associated with similar short-term success rates and postoperative complications.